NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2026
Back to search
Official data from USPTO
POWERED BY PARSORTIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
POWERED BY PARSORTIX
ST13
US500000079343310Class
1, 5, 9, 10
Filing
79343310
Registration
7423700
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
05/08/2026
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
03/24/2022
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
05/08/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
GB
Examiner
SINGH, DEEP K
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
CelLBxHealth Europe Ltd
Angle Europe Limited
Representatives
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; diagnostic reagents for in vitro use in biochemistryclinical chemistryscience and medical research; buffer solutions and reagents for use with laboratory apparatusbuffer solutions and reagents for scientific and research use for use with separation apparatus and analysis apparatus; diagnostic biomarkersnucleic acidsproteins and other biochemical ligands all of the foregoing being diagnostic preparations for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for scientific and clinical research
Class 5
Diagnostic medical reagents and assay components for testing of body fluidsincluding blood and plasmacells; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical use; all the foregoing not including any such goods that are prescription only pharmaceuticalsbut including such non-pharmaceutical goods that are for companion diagnostics
Class 9
Apparatusequipment and instruments for cytologyhistology and for use in detecting cancerous conditions not for medical usebut all for laboratory usediagnostic or general research use in the fields of cytology and histologyspecimen collection and handling vialspipettesburettesdispensing bottles for laboratory reagentsmicroplates and assay plates in the nature of test tubessample test tubes; Apparatusequipment and instruments for cytologyhistology and for use in detecting cancerous conditions not for medical usebut all for laboratory usediagnostic or general research use in the fields of cytology and histologyDNA analysis apparatus for laboratory useapparatus for analysing genes for laboratory use; laboratory apparatus in the nature of cassettes for harvesting rare cells for use in laboratorydiagnostic or general research use; cell analyzer in the nature of flow cytometers and flow-based analyzers providing quantitative cell analysis for scientificlaboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analysing blood not for medical useall for laboratory usediagnostic or general research usesample test tubesvialsdisposable dispenser syringespipettesdispensing bottles for laboratory reagentsmicroplates and assay plates in the nature of test tubes; parts and fittings for the aforesaid goodsnamely medical laboratory research instruments for use in the detection of cancer
Class 10
Medical apparatusequipment and instruments for laboratory analysis and clinical diagnosis of human diseasesmedical diagnostic apparatus for testing DNA and RNA samples and medical diagnostic testing instruments for processing and analysis of genetic samples using gene expression testsgene expression profiling assays and protein biomarkers; medical testing apparatusequipment and instruments for testing body fluidsblood and plasmacancer cellsfoetal cells; parts and fittings for the aforesaid goodsdiagnostic apparatusequipment and instruments for cytologyhistology and for use in detecting cancer
Publications
History of USPTO decisions and trademark events.
48 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/05/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/29/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/07/2024
FIMP
FINAL DISPOSITION PROCESSED
12/07/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/25/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/08/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/20/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/29/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/29/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/29/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/29/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/31/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/31/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/18/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/29/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/29/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/04/2023
GNFR
FINAL REFUSAL E-MAILED
08/04/2023
CNFR
FINAL REFUSAL WRITTEN
08/04/2023
DOCK
ASSIGNED TO EXAMINER
07/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/27/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/27/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/27/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/27/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/27/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/27/2023
RFNP
REFUSAL PROCESSED BY IB
01/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/10/2022
RFRR
REFUSAL PROCESSED BY MPU
12/09/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/29/2022
CNRT
NON-FINAL ACTION WRITTEN
09/28/2022
DOCK
ASSIGNED TO EXAMINER
09/26/2022
MAFR
APPLICATION FILING RECEIPT MAILED
06/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/23/2022
Continuous trademark protection
Get notified about every new filing that threatens POWERED BY PARSORTIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.